ProfileGDS5822 / ILMN_2666652
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 29% 17% 11% 24% 15% 27% 14% 15% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.129
GSM1276600PDAC Late Ablation Control 214.117
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.211
GSM1276603PDAC Late Ablation 213.124
GSM1276604PDAC Late Ablation 310.215
GSM1303940PDAC Late Ablation_anti-CTLA4 114.627
GSM1303941PDAC Late Ablation_anti-CTLA4 28.714
GSM1303942PDAC Late Ablation_anti-CTLA4 38.815